Biogena Group Invest AG (VIE:BIO)
Austria · Delayed Price · Currency is EUR 3.020
+0.020 (0.67%)
Feb 4, 2026, 5:35 PM CET
Biogena Group Invest AG Market Cap
Biogena Group Invest AG has a market cap or net worth of €12.05 million as of February 4, 2026. Its market cap has increased by 75.58% in one year.
Market Cap
12.05M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.02
Market Cap Chart
Since November 27, 2020, Biogena Group Invest AG's market cap has increased from 7.78M to 12.05M, an increase of 54.87%. That is a compound annual growth rate of 8.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 11.97M | - |
| Dec 30, 2025 | 11.97M | 100.00% |
| Dec 30, 2024 | 5.98M | -26.47% |
| Dec 29, 2023 | 8.14M | -20.93% |
| Dec 30, 2022 | 10.29M | -12.54% |
| Dec 30, 2021 | 11.77M | 31.40% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wiener Privatbank SE | 53.05M |
| Wolford Aktiengesellschaft | 45.23M |
| RATH Aktiengesellschaft | 37.50M |
| Hutter & Schrantz Stahlbau AG | 37.09M |
| Stadlauer Malzfabrik Aktiengesellschaft | 34.72M |
| Marinomed Biotech AG | 34.22M |
| Gurktaler Aktiengesellschaft | 32.78M |
| Warimpex Finanz- und Beteiligungs AG | 26.34M |